Although Ozempic has demonstrated promise for weight management, its official approved indication remains controlling blood sugar levels in adults with type 2 diabetes
Can you explain why that is
Brayden DJ, Gleeson J, Walsh EG
In the coming years, the global obesity drug market may continue shifting toward triple agonists, oral peptide drugs, long-acting therapies, and next-generation peptide engineering technologies
GLP-1 microdosing, starting below the standard dose or titrating more slowly, is an emerging conversation, but clinical evidence is still limited
While those results are encouraging, direct comparisons between Retatrutide and tirzepatide should be interpreted carefully because the medications have been studied in different clinical trials with different patient populations, treatment durations, and study designs